STAAR Surgical Company announced on Monday, October 27, 2025 that its special meeting of stockholders, which is the vote on the merger agreement with Alcon Inc., has been postponed to December 3, 2025 at 8:30 a.m. Pacific Time. The new record date for the meeting is the close of business on October 24, 2025, and shareholders holding shares on that date will be eligible to vote at the rescheduled meeting.
The meeting was originally adjourned to November 6, 2025, but ongoing discussions between STAAR and Alcon have led to the further delay. The merger, which involves the acquisition of STAAR’s implantable collamer lens business by Alcon, is a key strategic transaction for both companies and has been subject to regulatory and shareholder scrutiny.
The postponement extends the timeline for the final shareholder vote and may delay the completion of the merger. Shareholders and market participants will need to monitor the revised schedule, as the delay could impact the expected closing date and the integration timeline for Alcon’s expansion into the refractive surgery market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.